Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiying Qiu

Showing results (91-100 of 194) with videos related to

Pageof 20
Sort By:
Annals of Hematology|April 18, 2019
The benefit of chronic graft-versus-host disease in patients with acute myeloid leukemia relapsed after allogeneic stem cell transplantationZiwei Wang, Chunrong Yin, Weiping Zhang, et al.
Annals of Hematology|May 17, 2024
Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemiaTong Cui, Huiyu Li, Shiyuan Zhou, et al.
Annals of Transplantation|September 28, 2019
Pulmonary Infection Within 100 Days After Transplantation Impaired Platelet Recovery in Patients with Hematologic Malignancies: A Propensity-Score-Matched AnalysisRoujia Wang, Aijie Huang, Qi Chen, et al.
Molecular Cytogenetics|March 7, 2017
Multiple <i>MYO18A</i>-<i>PDGFRB</i> fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11)Guangying Sheng, Zhao Zeng, Jinlan Pan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2018
Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete RemissionJia Chen, Lingyi Yang, Yi Fan, et al.
Bone Marrow Transplantation|May 26, 2021
Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantationXi Sun, Jun Yang, Yu Cai, et al.
Stem Cell Research & Therapy|January 28, 2024
Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective studyLu Gao, Li Yang, Shiyuan Zhou, et al.
Vox Sanguinis|April 28, 2026
Platelet transfusion efficacy in pregnant women with thrombocytopenia: A retrospective studyShaoheng Chen, Huimin Deng, Xiao Wang, et al.
Hematology (Amsterdam, Netherlands)|February 25, 2021
Safety and efficacy of different doses of anthracyclines combined with arsenic trioxide and all-trans retinoic acid in the treatment of de novo acute promyelocytic leukemiaYaxue Wu, Peng Ke, Haixia Zhou, et al.
Frontiers in Immunology|May 13, 2022
The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell TransplantationMeng Shan, Danya Shen, Tiemei Song, et al.
Pageof 20

Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Annals of Hematology|April 18, 2019
The benefit of chronic graft-versus-host disease in patients with acute myeloid leukemia relapsed after allogeneic stem cell transplantationZiwei Wang, Chunrong Yin, Weiping Zhang, et al.
Annals of Hematology|May 17, 2024
Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemiaTong Cui, Huiyu Li, Shiyuan Zhou, et al.
Annals of Transplantation|September 28, 2019
Pulmonary Infection Within 100 Days After Transplantation Impaired Platelet Recovery in Patients with Hematologic Malignancies: A Propensity-Score-Matched AnalysisRoujia Wang, Aijie Huang, Qi Chen, et al.
Molecular Cytogenetics|March 7, 2017
Multiple <i>MYO18A</i>-<i>PDGFRB</i> fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11)Guangying Sheng, Zhao Zeng, Jinlan Pan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2018
Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete RemissionJia Chen, Lingyi Yang, Yi Fan, et al.
Bone Marrow Transplantation|May 26, 2021
Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantationXi Sun, Jun Yang, Yu Cai, et al.
Stem Cell Research & Therapy|January 28, 2024
Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective studyLu Gao, Li Yang, Shiyuan Zhou, et al.
Vox Sanguinis|April 28, 2026
Platelet transfusion efficacy in pregnant women with thrombocytopenia: A retrospective studyShaoheng Chen, Huimin Deng, Xiao Wang, et al.
Hematology (Amsterdam, Netherlands)|February 25, 2021
Safety and efficacy of different doses of anthracyclines combined with arsenic trioxide and all-trans retinoic acid in the treatment of de novo acute promyelocytic leukemiaYaxue Wu, Peng Ke, Haixia Zhou, et al.
Frontiers in Immunology|May 13, 2022
The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell TransplantationMeng Shan, Danya Shen, Tiemei Song, et al.
Pageof 20